SCHEMBL9738548

SCHEMBL9738548

CCOC(C)(OCC)c1nc(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)n(CC(CC)CC)n1

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9739156 0.94 AGTR1 (0.37) AGTR1
SCHEMBL9739075 0.92 AGTR1 (0.35) AGTR1
SCHEMBL9738541 0.91 AGTR1 (0.35) AGTR1
SCHEMBL9739541 0.91 AGTR1 (0.35) AGTR1
SCHEMBL9738528 0.89 AGTR1 (0.37) AGTR1
SCHEMBL9738118 0.89 AGTR1 (0.37) AGTR1
SCHEMBL9739655 0.89 AGTR1 (0.42) AGTR1
SCHEMBL9738787 0.88 AGTR1 (0.36) AGTR1
SCHEMBL9739102 0.87 AGTR1 (0.49) AGTR1
SCHEMBL9739885 0.86 AGTR1 (0.33) AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO claimed
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO disclosed